NDC codes

FDA NDC Directory
Product NDC (as listed)71335-9622Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71335-9622Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71335-9622-17133596220110 CAPSULE in 1 BOTTLE (71335-9622-1)Marketed from Jan 9, 2023
71335-9622-27133596220230 CAPSULE in 1 BOTTLE (71335-9622-2)Marketed from Jan 9, 2023
71335-9622-3713359622037 CAPSULE in 1 BOTTLE (71335-9622-3)Marketed from Jan 9, 2023
71335-9622-47133596220460 CAPSULE in 1 BOTTLE (71335-9622-4)Marketed from Jan 9, 2023
71335-9622-57133596220520 CAPSULE in 1 BOTTLE (71335-9622-5)Marketed from Jan 9, 2023
71335-9622-67133596220690 CAPSULE in 1 BOTTLE (71335-9622-6)Marketed from Jan 9, 2023
71335-9622-771335962207180 CAPSULE in 1 BOTTLE (71335-9622-7)Marketed from Jan 9, 2023
71335-9622-87133596220828 CAPSULE in 1 BOTTLE (71335-9622-8)Marketed from Jan 9, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Piroxicam
Generic name (nonproprietary)
piroxicam
Active ingredients
Piroxicam — 20 mg/1
Dosage form
Capsule
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 206152
Marketing start
Listing expires
Other FDA classes
Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers
Product ID 71335-9622_21e637ea-2418-47d3-82eb-f765e218da6cSPL ID 21e637ea-2418-47d3-82eb-f765e218da6cSPL set ID 8b8eb243-0efb-4777-b627-b7ae042f8823RxCUI 198108UNII 13T4O6VMAM

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335962201 followed by a unit qualifier and the quantity

Package 71335-9622-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Piroxicam capsule is indicated: For relief of the signs and symptoms of osteoarthritis. For relief of the signs and symptoms of rheumatoid arthritis. Piroxicam capsule, is a nonsteroidal anti-inflammatory drug indicated for Relief of the signs and symptoms of osteoarthritis (OA) ( 1 ) Relief of the signs and symptoms of rheumatoid arthritis (RA) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206152

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206152
ProductStrengthForm · routeLabelerProduct NDC
PiroxicamPiroxicam 20 mg/1CapsuleOralProficient Rx LP71205-203
PiroxicamPiroxicam 20 mg/1CapsuleOralMicro Labs Limited42571-177
PiroxicamPiroxicam 10 mg/1CapsuleOralMicro Labs Limited42571-176

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in